Country: Canada
Language: English
Source: Health Canada
CEPHALEXIN (CEPHALEXIN MONOHYDRATE)
VETOQUINOL N A INC
100MG
PASTE
CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 100MG
ORAL
6X15 ML SYR
Prescription
DOGS
Active ingredient group (AIG) number: 0105911005
CANCELLED POST MARKET
2019-02-04
VETOQUINOL N.-A. INC. Commercial Division 2000, CHEMIN GEORGES, LAVALTRIE, QC, J5T 3S5 Telephone: 450-586-2252 Order Desk: 800-363-1700 Fax: 450-586-4649 Website: www.vetoquinol.ca Email: info@vetoquinol.ca Every effort has been made to ensure the accuracy of the information published. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canada product label or package insert. VETOLEXIN ® VÉTOQUINOL Cephalexin Oral Paste VETERINARY USE ONLY Meat flavour PR VETOLEXIN 100 DIN 02353911 ACTIVE INGREDIENTS: Each mL of paste contains 100 mg Cephalexin (as monohydrate) in a triglyceride base. PR VETOLEXIN 250 DIN 02353938 ACTIVE INGREDIENTS: Each mL of paste contains 250 mg Cephalexin (as monohydrate) in a triglyceride base. INDICATION Antibiotic for the treatment of canine superficial pyoderma caused by susceptible strains of Staphylococcus intermedius. Note: It is recommended to obtain samples for in vitro culture and susceptibility testing prior to treatment. When this is not practical, culture and susceptibility results after initiation of VETOLEXIN therapy should be reviewed to confirm susceptibility of the pathogens. DOSAGE AND ADMINISTRATION Administer orally 25 mg/kg every 8 to 12 hours for 2 to 4 weeks. VETOLEXIN can be given with or without food. Administer directly into the dogs mouth or onto its food. The determination of a dosage regimen for any particular patient should take into consideration factors such as the severity and the nature of the infection, susceptibility of the causative organisms, clinical experience and the integrity of the host-defence mechanisms. When treating dogs with superficial pyoderma, it is recommended to continue treatment for 7 days beyond a clinical cure. If no clinical improvement is seen after 3-5 days of treatment, therapy should be discontinued and the case re-evaluated. HOW TO USE THE DIAL-A-DOSE SYRINGE 1. Hold the syringe with the tip pointing upward (make sure the cap is still secured) and the ma Read the complete document